Trials / Unknown
UnknownNCT02434978
Doppler-guided Endoscopic Treatment in Peptic Ulcer Bleeding
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 125 (estimated)
- Sponsor
- Odense University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
The present study is a randomized controlled trial (RCT) that examines if the outcome of peptic ulcer bleeding could be improved by use of doppler-guided endoscopic treatment.
Detailed description
This study evaluates if performance of a control endoscopy with doppler-guided endoscopic treatment is associated with an improved outcome in term of lower rate of rebleeding and lower rate of bleeding-related mortality. A potential risk of increased risk of complications (in particular perforation) among patients treated with control endoscopy is also evaluated. Outcomes are prospectively registered based on patient records.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Supplementary endoscopy with doppler-guided therapy | Patients randomized to supplementary doppler-guided therapy undergo repeat endoscopy with doppler evaluation within 24 hours from the primary endoscopy. At the control endoscopy the ulcer base is examined using a doppler device. If active doppler flow is demonstrated the ulcer is treated with a thermal probe until a control doppler-scan is negative. All patients are observed for rebleeding at a specialized GI-bleeding unit. |
| DRUG | IV. PPI | All patients receive 80mg of Esomeprazole iv as a bolus followed by 8mg Esomeprazole per hour for 72 hours. |
| OTHER | Endoscopic treatment at primary endoscopy | All patients are initially treated with endoscopic therapy using a minimum of two different treatment modalities. The primary endoscopy is performed wihtin 24 hours from time of admission to hospital |
Timeline
- Start date
- 2014-01-01
- Primary completion
- 2017-09-01
- Completion
- 2018-03-01
- First posted
- 2015-05-06
- Last updated
- 2017-04-20
Locations
2 sites across 1 country: Denmark
Source: ClinicalTrials.gov record NCT02434978. Inclusion in this directory is not an endorsement.